FDA Inspection 1228230 — Nanjing Xingyin Pharmaceutical Group Co. Ltd.
The FDA completed an inspection of Nanjing Xingyin Pharmaceutical Group Co. Ltd. on January 19, 2024 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)